105 related articles for article (PubMed ID: 430194)
1. Recirculation of lymphocytes and the use of indium-111.
Frost P; Frost H
J Nucl Med; 1979 Feb; 20(2):169-70. PubMed ID: 430194
[No Abstract] [Full Text] [Related]
2. Re: Labeling with indium-111 has detrimental effects on human lymphocytes.
Marcus CS
J Nucl Med; 1984 Mar; 25(3):406-7. PubMed ID: 6699730
[No Abstract] [Full Text] [Related]
3. Labeling with indium-111 has detrimental effects on human lymphocytes: concise communication.
ten Berge RJ; Natarajan AT; Hardeman MR; van Royen EA; Schellekens PT
J Nucl Med; 1983 Jul; 24(7):615-20. PubMed ID: 6864314
[TBL] [Abstract][Full Text] [Related]
4. Functional integrity of mouse spleen lymphocytes in vitro after radiolabeling with indium-111.
Dettman GL; Iosiphidis AH
Radiat Res; 1982 Oct; 92(1):95-104. PubMed ID: 7134386
[No Abstract] [Full Text] [Related]
5. Kinetics of indium-III labelled lymphocytes in normal subjects and patients with Hodgkin's disease.
Lavender JP; Goldman JM; Arnot RN; Thakur ML
Br Med J; 1977 Sep; 2(6090):797-9. PubMed ID: 912325
[TBL] [Abstract][Full Text] [Related]
6. The significance of chromosomal aberrations in indium-111-labeled lymphocytes.
Thakur ML; McAfee JG
J Nucl Med; 1984 Aug; 25(8):922-7. PubMed ID: 6431062
[No Abstract] [Full Text] [Related]
7. Indium-114m in dual-nuclide studies with Cr-51: comparison with indium-111.
Liburdy RP; Hunter D; Wyant AR; Tatsch RE
J Nucl Med; 1980 Oct; 21(10):992-4. PubMed ID: 7420200
[TBL] [Abstract][Full Text] [Related]
8. Gamma camera imaging of renal allografts using 111-InOx labelled autologous lymphocytes.
Pontes JE; Frost P; Pokorny M; Smith J
Invest Urol; 1980 May; 17(6):451-3. PubMed ID: 6768694
[TBL] [Abstract][Full Text] [Related]
9. Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observations.
Wagstaff J; Gibson C; Thatcher N; Ford WL; Sharma H; Crowther D
Clin Exp Immunol; 1981 Mar; 43(3):443-9. PubMed ID: 7285388
[TBL] [Abstract][Full Text] [Related]
10. Cell damage resulting from the labeling of rat lymphocytes and HeLa S3 cells with In-111 oxine.
Chisholm PM; Danpure HJ; Healey G; Osman S
J Nucl Med; 1979 Dec; 20(12):1308-11. PubMed ID: 119830
[TBL] [Abstract][Full Text] [Related]
11. Disparity between early and late In-111 white blood cell scans in a patient with proven abscess.
Krieves DA; McDougall IR
Clin Nucl Med; 1983 Jun; 8(6):243-5. PubMed ID: 6872393
[No Abstract] [Full Text] [Related]
12. [Polypositional quantitative scintigraphy of the bone marrow with Tc-99m sulfur colloid and In-113m in Hodgkin's disease].
Kanaev SV; Artiushkin AV; Volkov AA; Malinin AP; Shust VF
Probl Gematol Pereliv Krovi; 1980 Nov; 25(11):11-6. PubMed ID: 7443644
[No Abstract] [Full Text] [Related]
13. Blood cell labelling. Theory and methods: radiation hazards.
Trott NG; Akbari RB
Wien Klin Wochenschr; 1984 Feb; 96(3):92-5. PubMed ID: 6719926
[TBL] [Abstract][Full Text] [Related]
14. Scanning malignant neoplasms with gallium 67.
Edwards CL; Hayes RL
JAMA; 1970 May; 212(7):1182-91. PubMed ID: 4909824
[No Abstract] [Full Text] [Related]
15. Tumor-localizing radionuclides in retrospect and prospect.
Edwards CL
Semin Nucl Med; 1979 Jul; 9(3):186-9. PubMed ID: 388628
[No Abstract] [Full Text] [Related]
16. A look at radiolabeled blood cells.
Thakur ML
Int J Rad Appl Instrum B; 1986; 13(2):147-58. PubMed ID: 3533854
[No Abstract] [Full Text] [Related]
17. Allergic vasculitis following injection of 113mIn.
Geltner D; Friedman G; Segal S; Bar-On H
Isr J Med Sci; 1978 Apr; 14(4):486-8. PubMed ID: 669927
[No Abstract] [Full Text] [Related]
18. Adverse reactions following 3In-DTPA cisternography.
Alderson PO; Siegel BA
J Nucl Med; 1973 Aug; 14(8):609-11. PubMed ID: 4740507
[No Abstract] [Full Text] [Related]
19. Indications for investigation in Hodgkin's disease.
Smithers D
Proc R Soc Med; 1972 Jan; 65(1):61-2. PubMed ID: 5015479
[No Abstract] [Full Text] [Related]
20. Spleen scanning.
McCready VR; Ahuja S
Proc R Soc Med; 1969 Aug; 62(8):794-6. PubMed ID: 5810286
[No Abstract] [Full Text] [Related]
[Next] [New Search]